Company: NCEL
Filing Date: 2025-06-09
Form Type: F-4/A
Source: 0001213900-25-052354
Chunk: 468

Company: NewcelX Ltd.
Filing Date: 2025-06-09
Form: F-4/A
Chunk 468
---
 NLS’s net assets approximating the fair value. The excess of purchase price over net assets acquired has been allocated to intangible assets -primarilyimplied R&D however this allocation may be adjusted upon the closing of the merger based on the final purchase price analysis. 269

|                                             |     | Amount |            |
|:--------------------------------------------|:----|:-------|-----------:|
| Purchase price consideration(1)             |     | $      | 19,450,683 |
| Total consideration                         |     | $      | 19,450,683 |
| Assets acquired:                            |     |        |            |
| Cash                                        |     | $      |  4,219,094 |
| Prepayments and other current assets        |     |        |    560,157 |
| Property and equipment                      |     |        |      7,290 |
| Intangible assets-primarily implied R&D(2)  |     |        | 15,490,906 |
| Total assets acquired                       |     |        | 20,277,447 |
| Liabilities assumed:                        |     |        |            |
|                                             |     | $      |    826,764 |
| Total liabilities assumed                   |     |        |    826,764 |
| Estimated fair value of net assets acquired |     | $      | 19,450,683 |

____________ (1)See Note 5 below (2) The preliminary purchase price of $15,490,906 has been allocated to intangible assets -primarily implied R&D and will not be amortized but will be tested for impairment at least annually or more frequently if indicators of impairment arise. Additionally, intangible assets -primarily implied R&D is not expected to be deductible for tax purposes. Given the preliminary nature of the purchase price allocation at the time of this filing, the final allocation upon Closing may result in adjustments to intangible assets -primarily implied R&D. 3.Earnings Per Share and Common Share Reconciliation The pro forma basic and diluted earnings per share amounts presented in the unaudited pro forma condensed combined statement of operations are based upon the number of the outstanding NLS Common Shares and NLS Common Shares underlying NLS Preferred Shares pursuant to which Kadimastem agreed to convert its share capital in exchange for the right to receive a number of validly issued, fully paid and nonassessable NLS Common Shares, equal to the Exchange Ratio (as defined in the Mer